Aeterna Zentaris (AEZS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AEZS | BMY | AMGN | GILD | REGN |
| Company | Aeterna Zentaris | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.9650 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 1.9650 | 49.05 | 269.38 | 66.83 | 920.73 |
| Low | 1.9500 | 48.12 | 260.68 | 66.16 | 891.46 |
| Last | 1.9500 | 48.93 | 268.93 | 66.76 | 896.82 |
| Change | -0.0066 | +0.63 | +6.18 | +0.60 | +2.83 |
| % Change | -0.34% | +1.30% | +2.35% | +0.91% | +0.32% |
| Volume | 5,000 | 10,303,900 | 3,380,300 | 10,657,000 | 507,400 |
| 20-Day Average Volume | 13,510 | 11,303,500 | 2,246,435 | 6,455,920 | 437,680 |
| Previous Close | 1.9566 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0379 | 50.85 | 272.56 | 69.90 | 935.18 |
| 20-Day Raw Stochastic | 0.00% | 19.17% | 29.59% | 10.79% | 7.35% |
| 20-Day Relative Strength | 47.38% | 41.16% | 43.95% | 31.30% | 34.73% |
| Weighted Alpha | -36.34 | -28.90 | +7.67 | -24.32 | +12.43 |
| Today's Opinion | 24% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 8% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.27% since 04/12/24 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -0.87% since 04/12/24 |
| Low | 1.9500 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.0100 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -7.58% since 03/19/24 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -6.94% since 03/19/24 |
| Low | 1.9500 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.2600 on 04/05/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -2.50% since 01/19/24 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -3.92% since 01/19/24 |
| Low | 1.6800 on 02/22/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.3900 on 03/12/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +16.07% since 10/19/23 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +10.90% since 10/19/23 |
| Low | 1.3601 on 11/01/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 2.4154 on 12/08/23 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,501 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 4,856 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 4,500,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -16,550,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 120,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -5,630,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.57 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 03/27/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |